BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20124989)

  • 1. Comparison of antiplatelet potency of sarpogrelate, aspirin, and beraprost in healthy volunteers according to in-vitro closure time.
    Kim KM; Kim H; Chi HS; Park JS; Kim SB
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):262-5. PubMed ID: 20124989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
    Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
    Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in platelet function testing has a major influence on detection of aspirin resistance in healthy subjects.
    Bozic-Mijovski M; Rakusa M; Stegnar M
    Pathophysiol Haemost Thromb; 2008; 36(2):84-90. PubMed ID: 19127088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin.
    Takahashi S; Ushida M; Komine R; Shimizu A; Uchida T; Ishihara H; Shibano T; Watanabe G; Ikeda Y; Murata M
    Thromb Res; 2007; 119(4):517-24. PubMed ID: 16793119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering.
    Yamamoto T; Kamei M; Yokoi N; Yasuhara T; Tei M; Kinoshita S
    Am J Ophthalmol; 2004 Nov; 138(5):809-17. PubMed ID: 15531317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals.
    Haubelt H; Anders C; Vogt A; Hoerdt P; Seyfert UT; Hellstern P
    Br J Haematol; 2005 Sep; 130(5):759-67. PubMed ID: 16115134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes.
    Małek ŁA; Spiewak M; Filipiak KJ; Grabowski M; Szpotańska M; Rosiak M; Główczyńska R; Imiela T; Huczek Z; Opolski G
    Kardiol Pol; 2007 Jan; 65(1):40-5; discussion 46. PubMed ID: 17295159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers.
    Gladding PA; Webster MW; Farrell HB; Zeng IS; Park R; Ruijne N
    Am J Cardiol; 2008 Apr; 101(7):1060-3. PubMed ID: 18359332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
    Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
    Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
    Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
    Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients.
    Kotzailias N; Elwischger K; Sycha T; Rinner W; Quehenberger P; Auff E; Müller C
    J Stroke Cerebrovasc Dis; 2007; 16(5):199-202. PubMed ID: 17845916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ranitidine on the antiplatelet effects of aspirin in healthy human subjects.
    Lev EI; Ramabadran RS; Guthikonda S; Patel R; Kleiman A; Granada JF; DeLao T; Kleiman NS
    Am J Cardiol; 2007 Jan; 99(1):124-8. PubMed ID: 17196475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
    Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
    Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of oral antiplatelet responsiveness on the long-term prognosis after coronary stenting.
    Foussas SG; Zairis MN; Patsourakos NG; Makrygiannis SS; Adamopoulou EN; Handanis SM; Prekates AA; Fakiolas CN; Pissimissis EG; Olympios CD; Argyrakis SK
    Am Heart J; 2007 Oct; 154(4):676-81. PubMed ID: 17892990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of off-pump coronary artery bypass grafting on platelet activation in patients on aspirin therapy until surgery day.
    Suwalski G; Suwalski P; Filipiak KJ; Postuła M; Majstrak F; Opolski G
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):365-9; discussion 369. PubMed ID: 18550381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of diagnostic importance of platelet closure times measured by Platelet Function Analyzer--PFA 100 in dogs with endotoxemia.
    Yilmaz Z; Ilcol YO; Ulus IH
    Berl Munch Tierarztl Wochenschr; 2005; 118(7-8):341-8. PubMed ID: 16048047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.